As clinical trials grow more complex, biometrics teams are under pressure to reduce timelines, control costs, and ensure data quality. Artificial Intelligence (AI) is emerging as a powerful enabler in achieving these goals — transforming how data is managed, analyzed, and interpreted across clinical programs.

Join us for an insightful webinar on how AI is driving real value in biometrics by enhancing data integrity, accelerating interim insights, and strengthening the statistical underpinnings of trial results. The panelists will examine how AI supports early signal detection, adaptive design planning, and predictive analytics — leading to smarter decision-making and faster go/no-go determinations.

Key Topics

• How AI powered platforms are transforming data management, enabling real-time review, auto-reconciliation, and issue detection.
• The impact of AI on biostatistics, from automated programming and model optimization to reproducible, audit-ready outputs.
• Strategic considerations for sponsors when incorporating AI into biometrics workflows, including validation, compliance, and vendor oversight.

Speakers

• Steve Thacker, Vice President FSP
• Sheree King, Associate Director, Clinical Database Development
• Kunal Sanghavi, Associate Director Statistical Programming Management
• Juan Pablo Garcia Martinez, Principal Biostatistician